BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34747183)

  • 21. Minimally Invasive Approaches to Pancreatic Surgery.
    Magge D; Zureikat A; Hogg M; Zeh HJ
    Surg Oncol Clin N Am; 2016 Apr; 25(2):273-86. PubMed ID: 27013364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extended lymphadenectomy and vascular resection for pancreatic cancer].
    Kahlert C; M W B; Weitz J
    Chirurg; 2008 Dec; 79(12):1115-22. PubMed ID: 19002662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
    Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
    Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally invasive surgery for pancreatic cancer.
    Esposito A; Balduzzi A; De Pastena M; Fontana M; Casetti L; Ramera M; Bassi C; Salvia R
    Expert Rev Anticancer Ther; 2019 Nov; 19(11):947-958. PubMed ID: 31661984
    [No Abstract]   [Full Text] [Related]  

  • 25. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
    Tol JA; Gouma DJ; Bassi C; Dervenis C; Montorsi M; Adham M; Andrén-Sandberg A; Asbun HJ; Bockhorn M; Büchler MW; Conlon KC; Fernández-Cruz L; Fingerhut A; Friess H; Hartwig W; Izbicki JR; Lillemoe KD; Milicevic MN; Neoptolemos JP; Shrikhande SV; Vollmer CM; Yeo CJ; Charnley RM;
    Surgery; 2014 Sep; 156(3):591-600. PubMed ID: 25061003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic Distal Pancreatectomy for Left-Sided Pancreatic Cancer Using the "Caudo-Dorsal Artery First Approach".
    Ome Y; Seyama Y; Doi M; Muto J
    Ann Surg Oncol; 2019 Dec; 26(13):4464-4465. PubMed ID: 31502021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrograde artery first approach for "shoulder" pancreatic cancers in minimally invasive distal pancreatectomy.
    Tian F; Sun MQ; Lu J; Guo JC
    Surg Endosc; 2021 Jan; 35(1):74-80. PubMed ID: 32875408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive surgery for pancreatic cancer.
    Miyasaka Y; Ohtsuka T; Nakamura M
    Surg Today; 2021 Feb; 51(2):194-203. PubMed ID: 32857251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MINIMALLY INVASIVE SURGERY FOR PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS.
    Namur GN; Ribeiro TC; Souto MM; Figueira ER; Bacchella T; Jureidini R
    Arq Bras Cir Dig; 2016; 29(2):97-101. PubMed ID: 27438035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive pancreatic resection in the light of evidence state of the art.
    Nikov A; Záruba P; Ryska M; Pohnán R
    Rozhl Chir; 2021; 100(5):213-217. PubMed ID: 34465100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy.
    Pedrazzoli S
    Surg Oncol; 2022 Dec; 45():101858. PubMed ID: 36272250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival after pancreatectomy with major arterial resection and reconstruction.
    Stitzenberg KB; Watson JC; Roberts A; Kagan SA; Cohen SJ; Konski AA; Hoffman JP
    Ann Surg Oncol; 2008 May; 15(5):1399-406. PubMed ID: 18320285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New aspects of surgery for pancreatic cancer. Principles, results and evidence].
    Distler M; Grützmann R
    Pathologe; 2012 Nov; 33 Suppl 2():258-65. PubMed ID: 23108784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to improve local control of resected pancreas adenocarcinoma.
    Sugarbaker PH
    Surg Oncol; 2017 Mar; 26(1):63-70. PubMed ID: 28317586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical resection of pancreatic head cancer: What is the optimal extent of surgery?
    Kang MJ; Jang JY; Kim SW
    Cancer Lett; 2016 Nov; 382(2):259-265. PubMed ID: 26828131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.